165 related articles for article (PubMed ID: 32188269)
21. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in circulating nucleic acids in oncology.
Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
[TBL] [Abstract][Full Text] [Related]
23. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
24. Circulating exosomal MicroRNAs: New non-invasive biomarkers of non-communicable disease.
Jiménez-Avalos JA; Fernández-Macías JC; González-Palomo AK
Mol Biol Rep; 2021 Jan; 48(1):961-967. PubMed ID: 33313972
[TBL] [Abstract][Full Text] [Related]
25. The functional roles of exosomes-derived long non-coding RNA in human cancer.
Chen F; Wang N; Tan HY; Guo W; Zhang C; Feng Y
Cancer Biol Ther; 2019; 20(5):583-592. PubMed ID: 30739532
[TBL] [Abstract][Full Text] [Related]
26. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
27. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
[TBL] [Abstract][Full Text] [Related]
28. The Exosome Total Isolation Chip.
Liu F; Vermesh O; Mani V; Ge TJ; Madsen SJ; Sabour A; Hsu EC; Gowrishankar G; Kanada M; Jokerst JV; Sierra RG; Chang E; Lau K; Sridhar K; Bermudez A; Pitteri SJ; Stoyanova T; Sinclair R; Nair VS; Gambhir SS; Demirci U
ACS Nano; 2017 Nov; 11(11):10712-10723. PubMed ID: 29090896
[TBL] [Abstract][Full Text] [Related]
29. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
Ferracin M; Lupini L; Mangolini A; Negrini M
Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
[TBL] [Abstract][Full Text] [Related]
30. Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma.
Luo Y; Gui R
Turk J Haematol; 2020 Nov; 37(4):248-262. PubMed ID: 32812415
[TBL] [Abstract][Full Text] [Related]
31. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
32. Identification and analysis of circulating exosomal microRNA in human body fluids.
Lässer C
Methods Mol Biol; 2013; 1024():109-28. PubMed ID: 23719946
[TBL] [Abstract][Full Text] [Related]
33. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
[TBL] [Abstract][Full Text] [Related]
35. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.
Lin LY; Yang L; Zeng Q; Wang L; Chen ML; Zhao ZH; Ye GD; Luo QC; Lv PY; Guo QW; Li BA; Cai JC; Cai WY
Mol Cancer; 2018 Apr; 17(1):84. PubMed ID: 29690888
[TBL] [Abstract][Full Text] [Related]
36. Circulating cell-free nucleic acids: characteristics and applications.
Pös O; Biró O; Szemes T; Nagy B
Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
[TBL] [Abstract][Full Text] [Related]
37. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.
Kanwar SS; Dunlay CJ; Simeone DM; Nagrath S
Lab Chip; 2014 Jun; 14(11):1891-900. PubMed ID: 24722878
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives.
Movahedpour A; Ahmadi N; Ghasemi Y; Savardashtaki A; Shabaninejad Z
J Cell Biochem; 2019 Oct; 120(10):16316-16329. PubMed ID: 31257636
[TBL] [Abstract][Full Text] [Related]
39. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
40. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
San Lucas FA; Allenson K; Bernard V; Castillo J; Kim DU; Ellis K; Ehli EA; Davies GE; Petersen JL; Li D; Wolff R; Katz M; Varadhachary G; Wistuba I; Maitra A; Alvarez H
Ann Oncol; 2016 Apr; 27(4):635-41. PubMed ID: 26681674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
